Bone density and HLA antigens in patients with progressive systemic sclerosis [1]

Minerva Medica

Volumn 96, Issue 1, 2005, Pages 61-62

  D'Amore, M ^a,c   Minenna, G ^a   Fanelli, M ^a   D'Amore, S ^a   Favoino, B ^b  

^a UNIVERSITY OF BARI   (Italy)

^b Tissue Typing   (Italy)

^c Polyclinic ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA ANTIGEN; HLA DR11 ANTIGEN;

BLOOD VESSEL; BODY REGIONS; BONE DENSITY; BONE RADIOGRAPHY; CORRELATION COEFFICIENT; DEATH; DUAL ENERGY X RAY ABSORPTIOMETRY; GASTROINTESTINAL TRACT; HEREDITY; HUMAN; LETTER; LUMBAR SPINE; PATHOGENESIS; RISK FACTOR; SKIN FIBROSIS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ALLELES; BONE DENSITY; CHILD; FEMALE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROBABILITY; SCLERODERMA, DIFFUSE;

EID: 33745381867     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Mayes MD. Sclerodermia epidemiology. Rheum Dis Clin North Am 2003;29:239-54.
2. Broggini M, Baratelli E, Cappelli A, Galvani, Balzarini P. L'osteoporosi nella sclerodermia. Revisione della letteratura. Riv Ital Biol Med 2000;20;51-8.
3. Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A et al. Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 2004;22:313-8.
4. Favalli E, Ingegnoli F, Zeni S, Farè M, Fantini F. Tipizzazione del sistema HLA nella sclerosi sistemica. Reumatismo 2001;53:210-4.
5. Svejgaard A, Platz P, Ryder LP. HLA and disease 1982. A survey. Immunol Rev 1983;70:193-218.
6. Dyer P, Middleton D. Histocompatibility testing. Oxford: Oxford University Press, 1993.
7. Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 1995;14:407-12.